Pharmafile Logo
Pharmafocus logo
Advanced Search

takeover

Showing 13 posts of 28 posts found.

Mylan building

Mylan to relaunch $27.1bn hostile takeover of Perrigo

September 10, 2015
Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover

Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …

News
Nucynta (tapentadol)

Takeover hostilities resume between Depomed and Horizon

August 10, 2015
Sales and Marketing Depomed, horizon, hostile bid, nucynta, takeover, tapentadol

The bitter takeover row between Horizon and Depomed has escalated after Depomed dismissed its suitor’s latest advances, and warned it …

News
Deopmed logo

Horizon attempts a hostile $3bn Depomed takeover

July 9, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover

Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …

News
GSK image

GSK ploughs $95m into research institute

June 17, 2015
Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover

GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …

News
Shire image

AbbVie agrees to buy Shire for £32bn

July 18, 2014
Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover

Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …

News
abbvie image

AbbVie a step closer to Shire takeover

July 14, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover

Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …

News
Valeant image

Valeant goes hostile over Allergan hunt

June 19, 2014
Sales and Marketing Allergan, Botox, Valeant, hostile, takeover

Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …

News
AstraZeneca logo

AstraZeneca rejects Pfizer’s ‘final offer’

May 19, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …

News
Willetts image

Pfizer: ‘fewer scientists’ after merger

May 14, 2014
Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover

Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …

News
Pfizer image

Pfizer grilled by MPs – but AZ revelations shock

May 14, 2014
Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover

The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …

News

Wellcome Trust slams Pfizer/AstraZeneca bid

May 9, 2014
Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover

The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …

News

GSK raises bid for Human Genome Services

May 9, 2012
Research and Development, Sales and Marketing GSK, Human Genome Services, bid, takeover

The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …

News
Amgen HQ

Amgen and Actelion meet to “talk takeover”

December 13, 2010
Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026